Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Bioventus Inc.

ATEC Spine is a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, self-described as focusing on surgical techniques and technology.

ATEC Spine

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Ofir Paz

InspireMD, Inc.

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

SeaSpine Holdings Corporation

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Bioventus develops surgical orthobiologics and offers clinically efficacious and cost-effective solutions for active healing, self-described as a global leader in this area.

Metric
Company Name	Bioventus Inc.	ATEC Spine	InspireMD, Inc.	SeaSpine Holdings Corporation
Symbol	BVS		NSPR	SPNE
MSH ID	COM:BIOVENTUS	COM:ALPHATECSPINE	COM:INSPIREMD	COM:SEASPINE
Market	STOCKS	PRIVATE	STOCKS	STOCKS
Sector	Healthcare	Healthcare & Health Services	Healthcare	Healthcare
Industry	Medical - Devices	Medical Devices	Medical - Devices	Medical - Devices
Country	US	US	IL	US
Stage		Post-IPO Equity
Employee Count	995		68	523
Website	bioventus.com	alphatecspine.com	inspiremd.com	seaspine.com
LinkedIn
Founders

Metric
Market Cap	375.94M		61.65M
Enterprise Value
Monthly Web Traffic		11.77K		1.86K
Web Traffic Growth		-0.08		-0.23
Valuation
Raised Capital		150M

Metric
Revenue	512.35M	6.21M	191.45M
Revenue (LTM)
Revenue (NTM)
Gross Profit	319.35M	1.81M	114.59M
EBITDA	73.38M	-20.66M	-55.45M
Operating Income	16.01M	-20.89M	-60.98M
Net Income	-156.23M	-19.92M	-54.35M
EPS	-2.49	-0.82	-1.62
Diluted EPS	-2.49	-0.82	-1.62
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.66	0.29	0.60
Operating Profit Margin	0.16	-3.41	-0.32
EBITDA Margin	0.14	-3.33	-0.29
Net Profit Margin	-0.04	-2.63	-0.28
Return on Equity	-0.12	-0.55	-0.22
Return on Assets	-0.03	-0.31	-0.14
Return on Capital Employed	0.13	-0.49	-0.19

COM:BIOVENTUS

Bioventus

Last Close

11.51

22/11 21:00

Market Cap

697.47M

Beta: -

Volume Today

287.88K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-1.82	-4.86	-7.67
P/B Ratio	1.60	2.16	1.29
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	1.57	13.06
EV Multiple	6.83	-2.56	-1.35

Metric
Days Sales Outstanding	81.96	93.95	81.67
Days Payables Outstanding	34.49	55.16	98.11
Days Inventory Outstanding	194.34	181.31	343.32
Operating Cycle	282.00	319.02	412.40
Cash Conversion Cycle	243.73	241.09	315.99
Asset Turnover	0.68	0.15	0.51

Metric
Operating Cash Flow	15.34M	-16.38M	-33.51M
Free Cash Flow	7.98M	-16.76M	-59.55M
Cash Flow to Debt	0.04		-4.14
Operating Cash Flow/Sales	0.03	-2.02	-0.18
Free Cash Flow Yield	-0.00	-0.26

Metric
Cash & Equivalents	36.96M	9.64M	83.11M
Accounts Receivable	10.05M	-1.21M	-7.93M
Inventory	91.33M	2.11M	72.30M
Goodwill	7.46M		84.59M
Debt to Capitalization	0.72	0.04	0.03
Debt to Assets	0.49	0.03	0.12
Current Ratio	1.55	9.96	3.18
Quick Ratio	0.97	7.41	2.25

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.59	0.06
R&D to Revenue	0.03	1.46	0.10
SG&A to Revenue		1.86	0.22